Role of Prolactin Inducible Protein in Breast Cancer

Researchers describe the first evidence linking prolactin inducible protein (PIP) to the immune system's ability to recognize and destroy foreign cells, such as tumor cells. New research in prolactin inducible protein deficient mice that demonstrates the role of prolactin inducible protein  in cell-mediated immunity and suggests that this immune regulatory function may be protective against breast cancer … Continue reading Role of Prolactin Inducible Protein in Breast Cancer

Understanding pathology behind triple negative breast cancer

A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patient and may help them avoid unnecessary and invasive treatments. Using a database of 580 women with triple negative breast cancer (TNBC), the researchers found that survival … Continue reading Understanding pathology behind triple negative breast cancer